Buy These 3 Semiconductor Stocks Now and Thank Yourself in a Decade

Global chip sales rose 25.6% to over $791B in 2025 and could reach $1T with rising AI spending. TSMC controls ~72% of foundry revenue and Wall Street projects ~30% annualized long-term earnings growth; ASML is the sole supplier of EUV lithography with analysts forecasting ~20% long-term EPS growth; Arm increased ISA market share from 42% to 50% and is forecast to grow earnings ~32% annually but trades at ~154x trailing EPS. The article positions these three firms as structural beneficiaries of AI-driven demand and durable moats that support long-term investment theses.

Analysis

The market is pricing a multi-year hardware upcycle into a handful of oligopolists, which creates asymmetric second-order winners and losers across the supply chain. TSMC’s scale means marginal AI CPU/GPU demand converts to disproportionate fab utilization and pricing power, but that same concentration amplifies customer- and geopolitically-induced revenue volatility: a single large design win or an export-control shock can swing quarterly EBIT by high single digits.

ASML’s pricing leverage on EUV makes it the choke point for node progression; deliveries (and spare-parts lead times) are the real constraint on how fast nodes scale, so capex cutbacks at hyperscalers show up months later as order deferrals rather than immediate revenue declines. That creates a convex payoff: a modest rebound in hyperscaler capex lifts ASML margins substantially, while cyclical softness mainly compresses recognition timing.

Arm’s licensing model injects predictability into unit economics but concentrates regulatory and pricing risk into IP terms; the larger effect is ecosystem acceleration — more Arm tapeouts increase demand for EDA vendors, IP verification, and advanced packaging, shifting profit pools outward from pure foundry revenue.

Macro and policy are the dominant tail risks: durable onshoring subsidies (CHIPS) and progressive capacity builds by Samsung/Intel can erode sustainable pricing, while any meaningful AI software optimization that reduces FLOPS-per-inference needs could lengthen capacity cycles. Timeframes matter: earnings and order-book updates move prices in days-to-months, but structural market-share shifts and policy-driven capex play out over 12–36 months.

Key Decisions for Investors

• Pair trade (6–18 months): Long TSM (3% notional) / Short INTC (3% notional). Rationale: express foundry share and advanced-node pricing vs legacy IDM execution risk. Target 2:1 upside vs downside; implement stop-loss if the pair diverges >8% adverse within 60 days or if CHIPS Act incremental funding >$20bn is allocated to US fabs.
• Directional options (12–18 months): Buy ASML LEAP calls (12–18 month expiries) sized to 2–4% notional; if implied vol > historical, use call spreads to cap premium. Target 30–60% upside on an order-book normalization; hedge tail risk with 3-month 15% OTM puts sized 25–40% of LEAP notional.
• Structure-play (12–24 months): Accumulate ARM via Jan-2028 LEAPs funded by selling staggered 1–3 month puts (collect premium) — limit net allocation to 2–3% notional. Rationale: buy exposure to licensing flywheel while monetizing volatility; cap assignment risk by pre-defining max cash outlay and exit if regulatory scrutiny escalates materially.
• Income trade (30–60 days): Sell NVDA call spreads (short-dated 30–60 day) to monetize elevated IV — target premium collection equal to 2–5% of position value with defined width to cap gap risk. Use this as a volatility harvest; keep position size small (1–2% notional) given event-risk sensitivity.